| Age (years) |
59 (54, 64) |
59 (54, 64) |
56 (52, 59) |
58 (53, 64) |
63 (60, 65) |
0.002 |
| Sex |
|
|
|
|
|
0.107 |
| Male |
47 (31.76%) |
15 (34.09%) |
9 (29.03%) |
21 (39.62%) |
2 (10.00%) |
|
| Female |
101 (68.24%) |
29 (65.91%) |
22 (70.97%) |
32 (60.38%) |
18 (90.00%) |
|
| Occupation |
|
|
|
|
|
0.091 |
| Full time |
89 (64.96%) |
29 (70.73%) |
25 (80.65%) |
28 (56.00%) |
7 (46.67%) |
|
| Retired |
3 (2.19%) |
1 (2.44%) |
0 (0.00%) |
1 (2.00%) |
1 (6.67%) |
|
| Unemployed |
45 (32.85%) |
11 (26.83%) |
6 (19.35%) |
21 (42.00%) |
7 (46.67%) |
|
| Unknown |
11 |
3 |
0 |
3 |
5 |
|
| Highest Level of Education |
|
|
|
|
|
|
| No formal education |
33 (22.45%) |
13 (29.55%) |
9 (29.03%) |
9 (17.31%) |
2 (10.00%) |
|
| Basic education |
34 (23.13%) |
9 (20.45%) |
6 (19.35%) |
11 (21.15%) |
8 (40.00%) |
|
| Middle school leaver |
58 (39.46%) |
16 (36.36%) |
12 (38.71%) |
23 (44.23%) |
7 (35.00%) |
|
| Secondary or Technical |
15 (10.20%) |
4 (9.09%) |
4 (12.90%) |
6 (11.54%) |
1 (5.00%) |
|
| Tertiary |
7 (4.76%) |
2 (4.55%) |
0 (0.00%) |
3 (5.77%) |
2 (10.00%) |
|
| Unknown |
1 |
0 |
0 |
1 |
0 |
|
| marital_status |
|
|
|
|
|
|
| Married |
39 (26.35%) |
9 (20.45%) |
9 (29.03%) |
15 (28.30%) |
6 (30.00%) |
|
| Single |
7 (4.73%) |
2 (4.55%) |
2 (6.45%) |
3 (5.66%) |
0 (0.00%) |
|
| Divorced/Separated |
38 (25.68%) |
10 (22.73%) |
7 (22.58%) |
16 (30.19%) |
5 (25.00%) |
|
| Widow |
62 (41.89%) |
23 (52.27%) |
12 (38.71%) |
18 (33.96%) |
9 (45.00%) |
|
| Cohabiting |
2 (1.35%) |
0 (0.00%) |
1 (3.23%) |
1 (1.89%) |
0 (0.00%) |
|
| Religion |
|
|
|
|
|
0.275 |
| Muslim |
19 (12.93%) |
8 (18.60%) |
3 (9.68%) |
7 (13.21%) |
1 (5.00%) |
|
| Christian |
122 (82.99%) |
33 (76.74%) |
25 (80.65%) |
45 (84.91%) |
19 (95.00%) |
|
| Traditional |
1 (0.68%) |
1 (2.33%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
|
| None |
4 (2.72%) |
0 (0.00%) |
3 (9.68%) |
1 (1.89%) |
0 (0.00%) |
|
| Other |
1 (0.68%) |
1 (2.33%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
|
| Unknown |
1 |
1 |
0 |
0 |
0 |
|
| Number of Children |
4 (2, 5) |
4 (2, 5) |
4 (3, 6) |
3 (2, 5) |
3 (2, 4) |
0.185 |
| Unknown |
5 |
1 |
1 |
2 |
1 |
|
| Daily Wage |
|
|
|
|
|
0.374 |
| below median |
30 (47.62%) |
7 (35.00%) |
7 (43.75%) |
13 (61.90%) |
3 (50.00%) |
|
| above median |
33 (52.38%) |
13 (65.00%) |
9 (56.25%) |
8 (38.10%) |
3 (50.00%) |
|
| Unknown |
85 |
24 |
15 |
32 |
14 |
|
| HIV Disclosure |
|
|
|
|
|
0.620 |
| 1 |
100 (67.57%) |
28 (63.64%) |
21 (67.74%) |
35 (66.04%) |
16 (80.00%) |
|
| 2 |
48 (32.43%) |
16 (36.36%) |
10 (32.26%) |
18 (33.96%) |
4 (20.00%) |
|
| Duration since diagnosis (years) |
|
|
|
|
|
0.363 |
| < 5 years |
30 (21.28%) |
8 (18.60%) |
5 (18.52%) |
12 (23.08%) |
5 (26.32%) |
|
| 5-10 years |
77 (54.61%) |
27 (62.79%) |
18 (66.67%) |
25 (48.08%) |
7 (36.84%) |
|
| >10 years |
34 (24.11%) |
8 (18.60%) |
4 (14.81%) |
15 (28.85%) |
7 (36.84%) |
|
| Unknown |
7 |
1 |
4 |
1 |
1 |
|
| new_viral_load |
19 (0, 22) |
19 (0, 41) |
0 (0, 20) |
19 (0, 20) |
10 (0, 21) |
0.605 |
| Exposure to polypharmacy, including HIV medications |
|
|
|
|
|
<0.001 |
| Use of only HIV medications |
42 (28.38%) |
20 (45.45%) |
15 (48.39%) |
5 (9.43%) |
2 (10.00%) |
|
| Use of 1-3 medications, including medications for HIV |
64 (43.24%) |
23 (52.27%) |
14 (45.16%) |
22 (41.51%) |
5 (25.00%) |
|
| Use of 4 or more medications including medications for HIV |
42 (28.38%) |
1 (2.27%) |
2 (6.45%) |
26 (49.06%) |
13 (65.00%) |
|
| Exposure to polypharmacy, excluding HIV medications |
|
|
|
|
|
|
| Use of no-non-HIV medications |
42 (28.38%) |
20 (45.45%) |
15 (48.39%) |
5 (9.43%) |
2 (10.00%) |
|
| Use of 1-3 non-HIV medications |
81 (54.73%) |
24 (54.55%) |
15 (48.39%) |
31 (58.49%) |
11 (55.00%) |
|
| Use of 4 ore more non-HIV medications |
25 (16.89%) |
0 (0.00%) |
1 (3.23%) |
17 (32.08%) |
7 (35.00%) |
|
| Physical Activity (<600 MET-minutes/week) |
|
|
|
|
|
0.441 |
| Inactive |
47 (31.76%) |
10 (22.73%) |
10 (32.26%) |
19 (35.85%) |
8 (40.00%) |
|
| Active |
101 (68.24%) |
34 (77.27%) |
21 (67.74%) |
34 (64.15%) |
12 (60.00%) |
|
| new_bmi |
25.4 (22.5, 29.2) |
24.8 (22.4, 28.6) |
26.7 (23.2, 30.4) |
25.7 (22.4, 29.2) |
25.0 (22.0, 27.4) |
0.444 |
| Unknown |
1 |
0 |
0 |
1 |
0 |
|
| Body Mass Index Categories |
|
|
|
|
|
|
| Underweight |
5 (3.40%) |
2 (4.55%) |
1 (3.23%) |
1 (1.92%) |
1 (5.00%) |
|
| Normal Weight |
64 (43.54%) |
21 (47.73%) |
11 (35.48%) |
23 (44.23%) |
9 (45.00%) |
|
| Overweight |
48 (32.65%) |
14 (31.82%) |
11 (35.48%) |
16 (30.77%) |
7 (35.00%) |
|
| Obese |
30 (20.41%) |
7 (15.91%) |
8 (25.81%) |
12 (23.08%) |
3 (15.00%) |
|
| Unknown |
1 |
0 |
0 |
1 |
0 |
|
| audit_c_category_collapse |
|
|
|
|
|
0.694 |
| No Alcohol |
102 (68.92%) |
33 (75.00%) |
20 (64.52%) |
35 (66.04%) |
14 (70.00%) |
|
| Low |
35 (23.65%) |
9 (20.45%) |
10 (32.26%) |
11 (20.75%) |
5 (25.00%) |
|
| Moderate |
7 (4.73%) |
1 (2.27%) |
0 (0.00%) |
5 (9.43%) |
1 (5.00%) |
|
| High/Severe |
4 (2.70%) |
1 (2.27%) |
1 (3.23%) |
2 (3.77%) |
0 (0.00%) |
|
| diabetes_mellitus |
10 (6.76%) |
1 (2.27%) |
0 (0.00%) |
6 (11.32%) |
3 (15.00%) |
0.041 |
| dyslipidemia |
|
|
|
|
|
0.450 |
| 1 |
7 (4.73%) |
1 (2.27%) |
2 (6.45%) |
2 (3.77%) |
2 (10.00%) |
|
| 2 |
141 (95.27%) |
43 (97.73%) |
29 (93.55%) |
51 (96.23%) |
18 (90.00%) |
|
| renal_disease |
|
|
|
|
|
|
| Early |
72 (48.65%) |
24 (54.55%) |
15 (48.39%) |
27 (50.94%) |
6 (30.00%) |
|
| Failure |
1 (0.68%) |
0 (0.00%) |
1 (3.23%) |
0 (0.00%) |
0 (0.00%) |
|
| Moderate Disease |
46 (31.08%) |
13 (29.55%) |
8 (25.81%) |
18 (33.96%) |
7 (35.00%) |
|
| None |
27 (18.24%) |
6 (13.64%) |
7 (22.58%) |
8 (15.09%) |
6 (30.00%) |
|
| Severe |
2 (1.35%) |
1 (2.27%) |
0 (0.00%) |
0 (0.00%) |
1 (5.00%) |
|
| gds_score |
4.0 (2.0, 6.0) |
4.0 (2.5, 5.5) |
3.0 (2.0, 7.0) |
3.0 (1.0, 5.0) |
4.5 (2.0, 6.5) |
0.660 |
| rt_visual_impairment_category |
|
|
|
|
|
0.836 |
| Normal |
64 (43.54%) |
16 (36.36%) |
12 (38.71%) |
26 (50.00%) |
10 (50.00%) |
|
| Mild |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
|
| Moderate |
66 (44.90%) |
21 (47.73%) |
17 (54.84%) |
19 (36.54%) |
9 (45.00%) |
|
| Severe |
10 (6.80%) |
4 (9.09%) |
1 (3.23%) |
4 (7.69%) |
1 (5.00%) |
|
| Blind |
7 (4.76%) |
3 (6.82%) |
1 (3.23%) |
3 (5.77%) |
0 (0.00%) |
|
| Unknown |
1 |
0 |
0 |
1 |
0 |
|
| lt_visual_impairment_category |
|
|
|
|
|
0.338 |
| Normal |
75 (51.37%) |
20 (45.45%) |
14 (46.67%) |
30 (57.69%) |
11 (55.00%) |
|
| Mild |
5 (3.42%) |
3 (6.82%) |
1 (3.33%) |
1 (1.92%) |
0 (0.00%) |
|
| Moderate |
56 (38.36%) |
18 (40.91%) |
15 (50.00%) |
17 (32.69%) |
6 (30.00%) |
|
| Severe |
3 (2.05%) |
2 (4.55%) |
0 (0.00%) |
0 (0.00%) |
1 (5.00%) |
|
| Blind |
7 (4.79%) |
1 (2.27%) |
0 (0.00%) |
4 (7.69%) |
2 (10.00%) |
|
| Unknown |
2 |
0 |
1 |
1 |
0 |
|
| lt_hearing_problem |
46 (31.08%) |
13 (29.55%) |
8 (25.81%) |
18 (33.96%) |
7 (35.00%) |
0.850 |
| rt_hearing_problem |
61 (41.22%) |
14 (31.82%) |
11 (35.48%) |
22 (41.51%) |
14 (70.00%) |
0.031 |
| hillbone_medication_adherence |
36.00 (34.00, 36.00) |
35.00 (34.00, 36.00) |
36.00 (34.00, 36.00) |
35.50 (34.00, 36.00) |
36.00 (34.50, 36.00) |
0.902 |
| Unknown |
1 |
0 |
0 |
1 |
0 |
|